Agent Orange and CIDP VA Disability Claims

Chronic inflammatory demyelinating polyneuropathy, or CIDP, can cause progressive weakness, numbness, balance problems and loss of function in the arms and legs. For veterans exposed to Agent Orange, the disability claim can become complicated because VA does not list CIDP as an Agent Orange presumptive condition.

Qualifying herbicide exposure can still play a major role in the claim. A veteran whose service meets VA’s Agent Orange exposure rules does not have to prove physical contact with the herbicide. That presumed exposure can satisfy the in-service element of a direct CIDP claim, leaving the medical evidence to address whether the exposure contributed to the disease.

Other theories may apply depending on when symptoms began and what other disabilities VA has already service connected. CIDP may be considered under the rules for chronic diseases of the nervous system when symptoms appear within the applicable period, and secondary service connection may apply when another service-connected disability causes or aggravates neurological impairment.

• CIDP is not an Agent Orange presumptive condition. Only early-onset peripheral neuropathy is the nerve condition specifically included on VA’s herbicide presumptive list.
• Direct service connection is the main path to VA disability for CIDP. The medical nexus opinion must explain why the veteran’s CIDP is at least as likely as not related to the in-service exposure.
• CIDP has no dedicated VA diagnostic code. VA generally rates the neurological impairment under the peripheral nerve code that best matches the affected nerve or nerve group.
• The Board of Veterans’ Appeals denies or sends back most Agent Orange CIDP claims, but Hill & Ponton found that neurologist opinions carried significant weight in favorable decisions, especially when they addressed competing causes and explained the medical reasoning behind the conclusion.

Does the VA Recognize that Agent Orange Causes CIDP?

Medical literature does not establish Agent Orange as a specific cause of CIDP. CIDP itself remains a disease with an incompletely understood cause, although researchers recognize it as an immune-mediated disorder affecting peripheral nerves and nerve roots. Research on Agent Orange does provide evidence for peripheral neuropathy generally. The National Academies concluded in Veterans and Agent Orange: Update 2010 that there was limited or suggestive evidence of an association between herbicide exposure and early-onset peripheral neuropathy that may persist.

VA incorporated those findings into its regulation for early-onset peripheral neuropathy. It presumes a link to Agent Orange only when the condition becomes at least 10% disabling within one year after the veteran’s last qualifying herbicide exposure.

When Agent Orange Causes Neuropathy Later in Life

A veteran whose neurological symptoms began years later can still pursue direct service connection. In that situation, the medical opinion must address the delayed onset and explain why the veteran’s exposure history still supports a connection to the diagnosed neurological disease.

Learn How To File And Win Your VA Claim

Get our FREE book The Road to VA Compensation Benefits.

get the free book

A 2022 review by de la Monte and Goel examined Agent Orange exposure and peripheral nerve damage. The researchers reported peripheral neuropathy in 14.2% of a high perceived-exposure group compared with 5.9% of a low-exposure group, with risk increasing as exposure increased. The review addressed peripheral neuropathy broadly and did not establish a specific relationship between Agent Orange and CIDP.

For a VA appeal, a neurologist may need to explain how the veteran’s herbicide or chemical exposure history fits with the immune and neurological processes involved in CIDP. The Board of Veterans’ Appeals has accepted that kind of reasoning in some individual cases.

For example, the Board granted CIDP related to in-service toxic chemical exposure in Citation No. 23058221. In Citation No. 1230683, it granted CIDP involving an aircraft mechanic and crew chief who had worked with JP-4 aviation fuel and cleaning solvents.

Is CIDP a Presumptive VA Disability?

CIDP does not appear on VA’s Agent Orange presumptive disease list. It also does not have its own presumption under the criteria for Camp Lejeune, burn pits or radiation presumptions.

VA does recognize early-onset peripheral neuropathy as presumptively associated with herbicide exposure. The condition must become at least 10% disabling within one year after the veteran’s last qualifying exposure.

Early medical records can therefore become important when weakness, numbness, gait problems or other neurological symptoms began shortly after service. Service treatment records, separation records and treatment notes from the first year after discharge may document a neurological condition long before a physician eventually used the CIDP diagnosis.

The effective date can also differ depending on the legal path. An early-onset peripheral neuropathy claim may require consideration of special Agent Orange effective date rules, while a direct CIDP grant generally follows the effective date rules that apply to that particular claim and appeal history.

How Can a Veteran Prove CIDP Is Related to Agent Orange?

Direct service connection is the main path to VA disability for an Agent Orange CIDP claim. The veteran’s medical history, qualifying herbicide exposure and medical nexus evidence determine whether the claim can be granted. A direct CIDP claim generally needs three things:

1. A current CIDP diagnosis
2. An in-service event, injury or exposure
3. A medical nexus connecting the CIDP to that event or exposure

For veterans with qualifying Agent Orange service, the exposure presumption can establish the second element. The remaining medical question is whether the veteran’s CIDP is linked to that exposure.

In Board decision No. 1438695, the veteran’s service records established Vietnam service and presumed Agent Orange exposure. A favorable VA neurologist opinion then supported service connection for CIDP involving all four extremities.

The Board had a similar reasoning in Citation No. A22000184. The veteran’s treating neurologist concluded that Agent Orange exposure had at least as likely as not contributed to the chronic neuropathy. The record contained no contrary medical opinion, and the Board granted the claim.

CIDP may also qualify under the chronic disease rules for organic diseases of the nervous system when the evidence shows qualifying manifestations within one year after separation, or through secondary service connection. An Agent Orange condition like Type 2 diabetes can cause peripheral neuropathy that overlaps with CIDP. In those cases, medical evidence may need to distinguish the symptoms of diabetic neuropathy from CIDP and address whether the service-connected condition caused or aggravated the CIDP. VA must also avoid pyramiding (compensation for the same symptoms under multiple diagnoses).

How Does VA Rate CIDP After Service Connection?

VA has no diagnostic code specifically labeled CIDP. Adjudicators generally rate the neurological impairment under the peripheral nerve code or codes that best describe the affected nerves and functional loss.

The rating depends on the nerve involved and the severity of the paralysis or incomplete paralysis. CIDP affecting several extremities may result in multiple evaluations, and the bilateral factor may apply when compensable disabilities affect paired extremities.

What Evidence Helps Prove Agent Orange Caused CIDP?

• A confirmed CIDP diagnosis from a neurologist, supported by electrodiagnostic evidence of demyelination and any additional testing used to establish the diagnosis, such as cerebrospinal fluid testing or nerve-biopsy findings when those studies were performed.
• Treatment records documenting intravenous immunoglobulin, corticosteroids, plasma exchange or other therapy, along with the veteran’s response.
• Service records establishing qualifying Agent Orange exposure, including the DD-214, personnel records, unit information or other records showing covered service.
• A reasoned nexus opinion from a neurologist or other qualified specialist explaining why the exposure at least as likely as not caused or contributed to the CIDP.
• Discussion of other possible causes, including diabetes, alcohol use, medications, hereditary conditions, age and other medical risk factors relevant to the veteran.
• Lay statements describing when weakness, numbness, balance trouble or loss of dexterity began and how those symptoms progressed.
• Functional evidence for the rating, including the affected nerves, extremities, strength loss, atrophy, gait impairment and activities the veteran can no longer perform safely or consistently.

Functional descriptions fill gaps that clinical terminology misses. Difficulty buttoning clothing, writing, opening containers, standing from a chair, climbing stairs or walking without falling can show the practical effect of upper- and lower-extremity nerve impairment.

How Often Does VA Approve Agent Orange CIDP Appeals?

Hill & Ponton analyzed Board of Veterans’ Appeals decisions from 2021 through December 2025 and found the Board granted 7 of the 33 CIDP Agent Orange issues it adjudicated, denied 13 and remanded 12. Board appeals represent only a fraction of VA disability claims, but these decisions indicate how difficult it is to win a CIDP claim.

Hill & Ponton screened for decisions in which CIDP itself, or peripheral neuropathy expressly identified as CIDP, was claimed or adjudicated in connection with Agent Orange or other herbicide exposure.

Remands (when a case is sent back for additional development) accounted for 36.4% of the qualifying issues. In several of them, the Board found that VA medical opinions had stopped at the early-onset presumption without addressing whether Agent Orange could have directly caused the CIDP. The Board sent those cases back for opinions addressing direct causation.

In Board decision A23014058, decided June 22, 2023, the Board noted that herbicide exposure was presumed while CIDP was not included in the list. It granted direct service connection for peripheral neuropathy of all four extremities after crediting private opinions that explained a pathophysiological link between TCDD, immune response and CIDP over the VA examiner’s negative opinion.

In Board decision A24016712, decided April 5, 2024, the Board granted service connection for neuropathy of all four extremities associated with CIDP. The opinion it found highly probative came from a board-certified occupational and environmental medicine physician who had served as VA’s Acting Chief Consultant for Environmental Health. The physician addressed herbicide latency and immune findings in Ranch Hand veterans, and the VA examiner agreed with her assessment.

The strongest favorable opinions in the reviewed decisions addressed the veteran’s particular diagnosis, weighed competing explanations for the disease, discussed the autoimmune demyelinating mechanism of CIDP and cited medical literature involving dioxin exposure and immune dysfunction.

Why Were Claims Denied?

The denials came when the Board credited medical evidence pointing to another cause, treated the CIDP as idiopathic without a demonstrated herbicide connection or found the favorable nexus statement too speculative. Negative examiners frequently cited the long gap between military service and documented onset. Those denials generally held when no medical expert explained why delayed onset remained medically consistent with the claimed toxic exposure relationship.

A VA opinion that ends its review after stating that CIDP is not presumptive for Agent Orange exposure may leave direct causation unresolved. Several remands in the decisions analyzed by Hill & Ponton required examiners to consider the veteran’s exposure history, medical literature and competing risk factors separately from the presumptive rules.

Those outcomes vary widely, which makes the veteran’s own functional evidence important for VA purposes. Strength, gait, hand function, need for assistive devices and response to treatment give VA a more useful picture of disability severity than the CIDP diagnosis alone.

Get Help with a Denied Agent Orange CIDP Claim

The outcome of a CIDP appeal can depend on several overlapping issues, including whether VA considered direct service connection, whether the medical opinion addressed the veteran’s actual exposure history, delayed onset and competing causes, and whether VA stopped its review because CIDP is not presumptive.

If VA denied a CIDP claim involving Agent Orange or another in-service toxic exposure, Hill & Ponton can look at the decision and the supporting evidence and identify the best course of action. Get a free case evaluation today to determine your next step.

Content Reviewed by

Attorney Rachel Cheek

Rachel Cheek is an attorney at Hill & Ponton dedicated to helping veterans secure the benefits they deserve. A University of Florida graduate, she combines her passion for social justice with legal expertise to serve those most in need.